nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—lung cancer—malignant mesothelioma	0.879	1	CtDrD
Crizotinib—INSRR—testis—malignant mesothelioma	0.00203	0.0168	CbGeAlD
Crizotinib—ROS1—lung—malignant mesothelioma	0.00192	0.0158	CbGeAlD
Crizotinib—EPHA7—testis—malignant mesothelioma	0.00165	0.0137	CbGeAlD
Crizotinib—MUSK—testis—malignant mesothelioma	0.00154	0.0127	CbGeAlD
Crizotinib—NTRK1—decidua—malignant mesothelioma	0.0015	0.0124	CbGeAlD
Crizotinib—PRKD1—decidua—malignant mesothelioma	0.00129	0.0107	CbGeAlD
Crizotinib—LIMK1—decidua—malignant mesothelioma	0.00127	0.0105	CbGeAlD
Crizotinib—ANKK1—testis—malignant mesothelioma	0.00125	0.0103	CbGeAlD
Crizotinib—PRKD3—decidua—malignant mesothelioma	0.00124	0.0102	CbGeAlD
Crizotinib—CASK—decidua—malignant mesothelioma	0.00118	0.00977	CbGeAlD
Crizotinib—MAPK7—decidua—malignant mesothelioma	0.00115	0.00946	CbGeAlD
Crizotinib—MET—epithelium—malignant mesothelioma	0.00113	0.00938	CbGeAlD
Crizotinib—FES—decidua—malignant mesothelioma	0.00113	0.00937	CbGeAlD
Crizotinib—NEK9—lung—malignant mesothelioma	0.000951	0.00786	CbGeAlD
Crizotinib—NTRK1—testis—malignant mesothelioma	0.000949	0.00784	CbGeAlD
Crizotinib—BMPR1B—epithelium—malignant mesothelioma	0.00091	0.00751	CbGeAlD
Crizotinib—NEK9—testis—malignant mesothelioma	0.000898	0.00742	CbGeAlD
Crizotinib—IGF1R—epithelium—malignant mesothelioma	0.000892	0.00737	CbGeAlD
Crizotinib—TNK1—decidua—malignant mesothelioma	0.000868	0.00717	CbGeAlD
Crizotinib—TIE1—epithelium—malignant mesothelioma	0.000868	0.00717	CbGeAlD
Crizotinib—PRKD1—lung—malignant mesothelioma	0.000867	0.00716	CbGeAlD
Crizotinib—MAP4K1—decidua—malignant mesothelioma	0.000859	0.0071	CbGeAlD
Crizotinib—TNK2—decidua—malignant mesothelioma	0.000843	0.00696	CbGeAlD
Crizotinib—PRKD3—lung—malignant mesothelioma	0.000834	0.00689	CbGeAlD
Crizotinib—MAP4K2—decidua—malignant mesothelioma	0.000831	0.00686	CbGeAlD
Crizotinib—STK3—decidua—malignant mesothelioma	0.00082	0.00677	CbGeAlD
Crizotinib—TIE1—decidua—malignant mesothelioma	0.00082	0.00677	CbGeAlD
Crizotinib—PRKD1—testis—malignant mesothelioma	0.000818	0.00676	CbGeAlD
Crizotinib—DSTYK—lung—malignant mesothelioma	0.000814	0.00672	CbGeAlD
Crizotinib—LIMK1—testis—malignant mesothelioma	0.000807	0.00667	CbGeAlD
Crizotinib—LTK—lung—malignant mesothelioma	0.000795	0.00657	CbGeAlD
Crizotinib—CASK—lung—malignant mesothelioma	0.000795	0.00657	CbGeAlD
Crizotinib—TESK1—decidua—malignant mesothelioma	0.000792	0.00654	CbGeAlD
Crizotinib—PRKD3—testis—malignant mesothelioma	0.000787	0.0065	CbGeAlD
Crizotinib—MERTK—decidua—malignant mesothelioma	0.000771	0.00637	CbGeAlD
Crizotinib—MAPK7—lung—malignant mesothelioma	0.00077	0.00636	CbGeAlD
Crizotinib—TXK—lung—malignant mesothelioma	0.00077	0.00636	CbGeAlD
Crizotinib—DSTYK—testis—malignant mesothelioma	0.000768	0.00634	CbGeAlD
Crizotinib—FES—lung—malignant mesothelioma	0.000763	0.0063	CbGeAlD
Crizotinib—LIMK2—decidua—malignant mesothelioma	0.000754	0.00623	CbGeAlD
Crizotinib—NUAK2—decidua—malignant mesothelioma	0.000751	0.0062	CbGeAlD
Crizotinib—LTK—testis—malignant mesothelioma	0.00075	0.0062	CbGeAlD
Crizotinib—CASK—testis—malignant mesothelioma	0.00075	0.0062	CbGeAlD
Crizotinib—ACVR1—decidua—malignant mesothelioma	0.000746	0.00616	CbGeAlD
Crizotinib—MAPK7—testis—malignant mesothelioma	0.000727	0.006	CbGeAlD
Crizotinib—TXK—testis—malignant mesothelioma	0.000727	0.006	CbGeAlD
Crizotinib—MET—lung—malignant mesothelioma	0.000721	0.00596	CbGeAlD
Crizotinib—EPHA8—testis—malignant mesothelioma	0.00072	0.00594	CbGeAlD
Crizotinib—FES—testis—malignant mesothelioma	0.00072	0.00594	CbGeAlD
Crizotinib—RIPK2—epithelium—malignant mesothelioma	0.000713	0.00589	CbGeAlD
Crizotinib—BMP2K—decidua—malignant mesothelioma	0.000703	0.00581	CbGeAlD
Crizotinib—CDK7—lung—malignant mesothelioma	0.000697	0.00576	CbGeAlD
Crizotinib—TAOK2—lung—malignant mesothelioma	0.000692	0.00572	CbGeAlD
Crizotinib—MET—testis—malignant mesothelioma	0.00068	0.00562	CbGeAlD
Crizotinib—PTK2B—decidua—malignant mesothelioma	0.000679	0.00561	CbGeAlD
Crizotinib—RIPK2—decidua—malignant mesothelioma	0.000674	0.00556	CbGeAlD
Crizotinib—ACVR1B—lung—malignant mesothelioma	0.000667	0.00551	CbGeAlD
Crizotinib—EPHA3—lung—malignant mesothelioma	0.000667	0.00551	CbGeAlD
Crizotinib—PTK2—epithelium—malignant mesothelioma	0.000662	0.00547	CbGeAlD
Crizotinib—CDK7—testis—malignant mesothelioma	0.000658	0.00544	CbGeAlD
Crizotinib—TAOK2—testis—malignant mesothelioma	0.000653	0.00539	CbGeAlD
Crizotinib—RPS6KB1—epithelium—malignant mesothelioma	0.000637	0.00526	CbGeAlD
Crizotinib—JAK3—lung—malignant mesothelioma	0.000636	0.00525	CbGeAlD
Crizotinib—DCLK1—lung—malignant mesothelioma	0.000632	0.00522	CbGeAlD
Crizotinib—EPHA3—testis—malignant mesothelioma	0.000629	0.0052	CbGeAlD
Crizotinib—ACVR1B—testis—malignant mesothelioma	0.000629	0.0052	CbGeAlD
Crizotinib—PLK4—lung—malignant mesothelioma	0.000628	0.00519	CbGeAlD
Crizotinib—TBK1—decidua—malignant mesothelioma	0.000625	0.00517	CbGeAlD
Crizotinib—PTK2—decidua—malignant mesothelioma	0.000625	0.00517	CbGeAlD
Crizotinib—STK4—lung—malignant mesothelioma	0.000624	0.00516	CbGeAlD
Crizotinib—TYK2—decidua—malignant mesothelioma	0.000621	0.00513	CbGeAlD
Crizotinib—IRAK1—decidua—malignant mesothelioma	0.000613	0.00506	CbGeAlD
Crizotinib—EPHB4—epithelium—malignant mesothelioma	0.000603	0.00498	CbGeAlD
Crizotinib—RPS6KB1—decidua—malignant mesothelioma	0.000602	0.00497	CbGeAlD
Crizotinib—JAK3—testis—malignant mesothelioma	0.0006	0.00496	CbGeAlD
Crizotinib—EPHA6—testis—malignant mesothelioma	0.0006	0.00496	CbGeAlD
Crizotinib—JAK2—epithelium—malignant mesothelioma	0.000598	0.00494	CbGeAlD
Crizotinib—LCK—decidua—malignant mesothelioma	0.000598	0.00494	CbGeAlD
Crizotinib—FGR—decidua—malignant mesothelioma	0.000598	0.00494	CbGeAlD
Crizotinib—DCLK1—testis—malignant mesothelioma	0.000596	0.00493	CbGeAlD
Crizotinib—AXL—decidua—malignant mesothelioma	0.000596	0.00492	CbGeAlD
Crizotinib—PLK4—testis—malignant mesothelioma	0.000593	0.00489	CbGeAlD
Crizotinib—EPHA2—epithelium—malignant mesothelioma	0.000591	0.00488	CbGeAlD
Crizotinib—FER—lung—malignant mesothelioma	0.00059	0.00487	CbGeAlD
Crizotinib—ALK—lung—malignant mesothelioma	0.00059	0.00487	CbGeAlD
Crizotinib—STK4—testis—malignant mesothelioma	0.000589	0.00486	CbGeAlD
Crizotinib—TNK1—lung—malignant mesothelioma	0.000584	0.00482	CbGeAlD
Crizotinib—MAP4K1—lung—malignant mesothelioma	0.000578	0.00477	CbGeAlD
Crizotinib—BMPR1B—lung—malignant mesothelioma	0.000578	0.00477	CbGeAlD
Crizotinib—MAP3K19—lung—malignant mesothelioma	0.000578	0.00477	CbGeAlD
Crizotinib—TEK—epithelium—malignant mesothelioma	0.000577	0.00476	CbGeAlD
Crizotinib—SLK—decidua—malignant mesothelioma	0.000573	0.00474	CbGeAlD
Crizotinib—EPHB4—decidua—malignant mesothelioma	0.000569	0.0047	CbGeAlD
Crizotinib—TNK2—lung—malignant mesothelioma	0.000567	0.00468	CbGeAlD
Crizotinib—IGF1R—lung—malignant mesothelioma	0.000567	0.00468	CbGeAlD
Crizotinib—JAK2—decidua—malignant mesothelioma	0.000565	0.00467	CbGeAlD
Crizotinib—MAP4K2—lung—malignant mesothelioma	0.000559	0.00462	CbGeAlD
Crizotinib—EPHA2—decidua—malignant mesothelioma	0.000558	0.00461	CbGeAlD
Crizotinib—FER—testis—malignant mesothelioma	0.000557	0.0046	CbGeAlD
Crizotinib—ALK—testis—malignant mesothelioma	0.000557	0.0046	CbGeAlD
Crizotinib—TYRO3—testis—malignant mesothelioma	0.000557	0.0046	CbGeAlD
Crizotinib—TIE1—lung—malignant mesothelioma	0.000551	0.00455	CbGeAlD
Crizotinib—STK3—lung—malignant mesothelioma	0.000551	0.00455	CbGeAlD
Crizotinib—TNK1—testis—malignant mesothelioma	0.000551	0.00455	CbGeAlD
Crizotinib—MAP4K1—testis—malignant mesothelioma	0.000545	0.0045	CbGeAlD
Crizotinib—MAP3K19—testis—malignant mesothelioma	0.000545	0.0045	CbGeAlD
Crizotinib—BMPR1B—testis—malignant mesothelioma	0.000545	0.0045	CbGeAlD
Crizotinib—MAP4K5—decidua—malignant mesothelioma	0.000545	0.0045	CbGeAlD
Crizotinib—MAP3K3—decidua—malignant mesothelioma	0.000545	0.0045	CbGeAlD
Crizotinib—TEK—decidua—malignant mesothelioma	0.000545	0.0045	CbGeAlD
Crizotinib—AURKA—lung—malignant mesothelioma	0.000537	0.00444	CbGeAlD
Crizotinib—TNK2—testis—malignant mesothelioma	0.000535	0.00442	CbGeAlD
Crizotinib—IGF1R—testis—malignant mesothelioma	0.000535	0.00442	CbGeAlD
Crizotinib—TESK1—lung—malignant mesothelioma	0.000533	0.0044	CbGeAlD
Crizotinib—MAP4K2—testis—malignant mesothelioma	0.000527	0.00436	CbGeAlD
Crizotinib—EPHB6—decidua—malignant mesothelioma	0.000521	0.0043	CbGeAlD
Crizotinib—STK3—testis—malignant mesothelioma	0.00052	0.0043	CbGeAlD
Crizotinib—TIE1—testis—malignant mesothelioma	0.00052	0.0043	CbGeAlD
Crizotinib—MERTK—lung—malignant mesothelioma	0.000518	0.00428	CbGeAlD
Crizotinib—SRC—epithelium—malignant mesothelioma	0.000512	0.00423	CbGeAlD
Crizotinib—LIMK2—lung—malignant mesothelioma	0.000507	0.00419	CbGeAlD
Crizotinib—AURKA—testis—malignant mesothelioma	0.000507	0.00419	CbGeAlD
Crizotinib—NUAK2—lung—malignant mesothelioma	0.000505	0.00417	CbGeAlD
Crizotinib—YES1—decidua—malignant mesothelioma	0.000503	0.00416	CbGeAlD
Crizotinib—TESK1—testis—malignant mesothelioma	0.000503	0.00415	CbGeAlD
Crizotinib—ACVR1—lung—malignant mesothelioma	0.000502	0.00414	CbGeAlD
Crizotinib—FLT3—lung—malignant mesothelioma	0.000502	0.00414	CbGeAlD
Crizotinib—MAP3K12—lung—malignant mesothelioma	0.000502	0.00414	CbGeAlD
Crizotinib—STK10—decidua—malignant mesothelioma	0.000499	0.00412	CbGeAlD
Crizotinib—TAOK3—decidua—malignant mesothelioma	0.000497	0.0041	CbGeAlD
Crizotinib—STK35—lung—malignant mesothelioma	0.000491	0.00406	CbGeAlD
Crizotinib—MERTK—testis—malignant mesothelioma	0.000489	0.00404	CbGeAlD
Crizotinib—SRC—decidua—malignant mesothelioma	0.000484	0.004	CbGeAlD
Crizotinib—ABL2—lung—malignant mesothelioma	0.000479	0.00396	CbGeAlD
Crizotinib—LIMK2—testis—malignant mesothelioma	0.000478	0.00395	CbGeAlD
Crizotinib—NUAK2—testis—malignant mesothelioma	0.000477	0.00394	CbGeAlD
Crizotinib—MAP3K12—testis—malignant mesothelioma	0.000473	0.00391	CbGeAlD
Crizotinib—ACVR1—testis—malignant mesothelioma	0.000473	0.00391	CbGeAlD
Crizotinib—FLT3—testis—malignant mesothelioma	0.000473	0.00391	CbGeAlD
Crizotinib—BMP2K—lung—malignant mesothelioma	0.000473	0.00391	CbGeAlD
Crizotinib—STK35—testis—malignant mesothelioma	0.000464	0.00383	CbGeAlD
Crizotinib—PTK2B—lung—malignant mesothelioma	0.000457	0.00377	CbGeAlD
Crizotinib—RIPK2—lung—malignant mesothelioma	0.000453	0.00374	CbGeAlD
Crizotinib—ABL2—testis—malignant mesothelioma	0.000452	0.00373	CbGeAlD
Crizotinib—BMP2K—testis—malignant mesothelioma	0.000446	0.00369	CbGeAlD
Crizotinib—EPHA4—lung—malignant mesothelioma	0.000438	0.00362	CbGeAlD
Crizotinib—CSF1R—decidua—malignant mesothelioma	0.000434	0.00359	CbGeAlD
Crizotinib—PTK2B—testis—malignant mesothelioma	0.000431	0.00356	CbGeAlD
Crizotinib—MAP3K2—lung—malignant mesothelioma	0.00043	0.00355	CbGeAlD
Crizotinib—RIPK2—testis—malignant mesothelioma	0.000427	0.00353	CbGeAlD
Crizotinib—PTK2—lung—malignant mesothelioma	0.000421	0.00347	CbGeAlD
Crizotinib—TBK1—lung—malignant mesothelioma	0.000421	0.00347	CbGeAlD
Crizotinib—TYK2—lung—malignant mesothelioma	0.000418	0.00345	CbGeAlD
Crizotinib—EPHA4—testis—malignant mesothelioma	0.000413	0.00341	CbGeAlD
Crizotinib—IRAK1—lung—malignant mesothelioma	0.000412	0.00341	CbGeAlD
Crizotinib—MAP3K2—testis—malignant mesothelioma	0.000405	0.00335	CbGeAlD
Crizotinib—RPS6KB1—lung—malignant mesothelioma	0.000405	0.00334	CbGeAlD
Crizotinib—FGR—lung—malignant mesothelioma	0.000402	0.00332	CbGeAlD
Crizotinib—LCK—lung—malignant mesothelioma	0.000402	0.00332	CbGeAlD
Crizotinib—AXL—lung—malignant mesothelioma	0.000401	0.00331	CbGeAlD
Crizotinib—TBK1—testis—malignant mesothelioma	0.000397	0.00328	CbGeAlD
Crizotinib—PTK2—testis—malignant mesothelioma	0.000397	0.00328	CbGeAlD
Crizotinib—TYK2—testis—malignant mesothelioma	0.000394	0.00326	CbGeAlD
Crizotinib—IRAK1—testis—malignant mesothelioma	0.000389	0.00321	CbGeAlD
Crizotinib—SLK—lung—malignant mesothelioma	0.000386	0.00319	CbGeAlD
Crizotinib—EPHB4—lung—malignant mesothelioma	0.000383	0.00316	CbGeAlD
Crizotinib—RPS6KB1—testis—malignant mesothelioma	0.000382	0.00315	CbGeAlD
Crizotinib—JAK2—lung—malignant mesothelioma	0.00038	0.00314	CbGeAlD
Crizotinib—FGR—testis—malignant mesothelioma	0.000379	0.00313	CbGeAlD
Crizotinib—LCK—testis—malignant mesothelioma	0.000379	0.00313	CbGeAlD
Crizotinib—AXL—testis—malignant mesothelioma	0.000378	0.00312	CbGeAlD
Crizotinib—EPHA2—lung—malignant mesothelioma	0.000376	0.0031	CbGeAlD
Crizotinib—MAP3K3—lung—malignant mesothelioma	0.000366	0.00303	CbGeAlD
Crizotinib—MAP4K5—lung—malignant mesothelioma	0.000366	0.00303	CbGeAlD
Crizotinib—TEK—lung—malignant mesothelioma	0.000366	0.00303	CbGeAlD
Crizotinib—SLK—testis—malignant mesothelioma	0.000364	0.00301	CbGeAlD
Crizotinib—EPHB4—testis—malignant mesothelioma	0.000361	0.00298	CbGeAlD
Crizotinib—JAK2—testis—malignant mesothelioma	0.000359	0.00296	CbGeAlD
Crizotinib—EPHA2—testis—malignant mesothelioma	0.000354	0.00293	CbGeAlD
Crizotinib—EPHB6—lung—malignant mesothelioma	0.00035	0.00289	CbGeAlD
Crizotinib—MAP3K3—testis—malignant mesothelioma	0.000346	0.00286	CbGeAlD
Crizotinib—TEK—testis—malignant mesothelioma	0.000346	0.00286	CbGeAlD
Crizotinib—MAP4K5—testis—malignant mesothelioma	0.000346	0.00286	CbGeAlD
Crizotinib—ABL1—decidua—malignant mesothelioma	0.000343	0.00284	CbGeAlD
Crizotinib—YES1—lung—malignant mesothelioma	0.000338	0.0028	CbGeAlD
Crizotinib—STK10—lung—malignant mesothelioma	0.000335	0.00277	CbGeAlD
Crizotinib—TAOK3—lung—malignant mesothelioma	0.000334	0.00276	CbGeAlD
Crizotinib—EPHB6—testis—malignant mesothelioma	0.00033	0.00273	CbGeAlD
Crizotinib—SRC—lung—malignant mesothelioma	0.000326	0.00269	CbGeAlD
Crizotinib—YES1—testis—malignant mesothelioma	0.000319	0.00264	CbGeAlD
Crizotinib—STK10—testis—malignant mesothelioma	0.000316	0.00261	CbGeAlD
Crizotinib—TAOK3—testis—malignant mesothelioma	0.000315	0.0026	CbGeAlD
Crizotinib—SRC—testis—malignant mesothelioma	0.000307	0.00254	CbGeAlD
Crizotinib—CSF1R—lung—malignant mesothelioma	0.000292	0.00241	CbGeAlD
Crizotinib—CSF1R—testis—malignant mesothelioma	0.000276	0.00228	CbGeAlD
Crizotinib—ABL1—lung—malignant mesothelioma	0.000231	0.00191	CbGeAlD
Crizotinib—ABL1—testis—malignant mesothelioma	0.000218	0.0018	CbGeAlD
Crizotinib—CYP3A5—lung—malignant mesothelioma	0.000135	0.00112	CbGeAlD
Crizotinib—ABCB1—epithelium—malignant mesothelioma	0.000113	0.000934	CbGeAlD
Crizotinib—ABCB1—decidua—malignant mesothelioma	0.000107	0.000882	CbGeAlD
Crizotinib—ABCB1—lung—malignant mesothelioma	7.18e-05	0.000593	CbGeAlD
Crizotinib—ABCB1—testis—malignant mesothelioma	6.78e-05	0.00056	CbGeAlD
